Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 CAD | 0.00% | 0.00% | -3.08% |
Mar. 21 | LifeSpeak Inc. Reports Q4 2023 Adjusted Loss of $0.05 Per Share | MT |
Mar. 21 | Transcript : LifeSpeak Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.08% | 27.2M | - | ||
+11.17% | 316B | B- | ||
+24.75% | 212B | B+ | ||
+2.41% | 147B | B | ||
+10.65% | 56.54B | D+ | ||
+8.71% | 32.23B | B+ | ||
-4.57% | 29.66B | C+ | ||
+103.03% | 21.88B | D+ | ||
+20.22% | 19.71B | B- | ||
+0.04% | 14.5B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LSPK Stock
- Ratings LifeSpeak Inc.